Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Number of holders
-
222
-
Total Shares
-
110M
-
Shares change
-
+15.2M
-
Total reported value, excl. options
-
$1.38B
-
Value change
-
+$165M
-
Put/Call ratio
-
1.02
-
Number of buys
-
139
-
Number of sells
-
-68
-
Price
-
$12.57
Significant Holders of Rocket Pharmaceuticals, Inc. - Common Stock, $0.01 par value (RCKT)
https://fintel.io/s/us/spy
SPDR S&P 500 ETF (SPY) has 4,492 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 596,032,956 shares.
Largest shareholders include Barclays Plc, 1832 Asset Management L.P., Optiver Holding B.V., Optiver Holding B.V., Ctc Llc, Jane Street Group, Llc, Jane Street Group, Llc, Simplex Trading, Llc, Citadel Advisors Llc, and Citadel Advisors Llc .
This table shows the top 25 institutional owners of the company. This data is sourced directly from the SEC via 13F and NPORT filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.